Latest News about DXCM
Recent news which mentions DXCM
From Motley Fool
Markets Have Another Strong Week As S&P 500 Erases Initial Losses From Russia-Ukraine War
March 25, 2022
From Benzinga
Is DexCom a Buy?
March 23, 2022
From Motley Fool
2 Growth Stocks With More Upside Than Shiba Inu
March 16, 2022
From Motley Fool
Markets Fall In Anticipation Of This Week's Fed Decision
March 14, 2022
From Benzinga
DexCom to Take Its Technology International
March 13, 2022
From Motley Fool
From Motley Fool
These 2 Millionaire-Maker Stocks Still Promise Solid Returns
March 09, 2022
From Motley Fool
From Benzinga
Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade
February 28, 2022
From Motley Fool
Up 700%, DexCom Stock Still Has Tons of Room To Run
February 27, 2022
From Motley Fool
Bull vs. Bear: DexCom Stock
February 20, 2022
From Motley Fool
Scared of the Bear? Buy These 3 Healthcare Stocks
February 18, 2022
From Motley Fool
The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO
February 11, 2022
From Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
February 10, 2022
From Benzinga
Earnings Scheduled For February 10, 2022
February 10, 2022
From Benzinga
2 Unstoppable Growth Stocks to Buy in 2022 and Beyond
February 08, 2022
From Motley Fool
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2022
February 03, 2022
From Benzinga
7 Best Mutual Funds to Buy for February
January 28, 2022
From InvestorPlace
Here's Why Insulet Stock Is Jumping Higher on Friday
January 28, 2022
From Motley Fool
2 Growth Stocks I'd Buy Right Now
January 25, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022
January 19, 2022
From Benzinga